全文获取类型
收费全文 | 9897篇 |
免费 | 2538篇 |
国内免费 | 128篇 |
专业分类
耳鼻咽喉 | 378篇 |
儿科学 | 229篇 |
妇产科学 | 276篇 |
基础医学 | 286篇 |
口腔科学 | 161篇 |
临床医学 | 2996篇 |
内科学 | 1901篇 |
皮肤病学 | 328篇 |
神经病学 | 772篇 |
特种医学 | 340篇 |
外科学 | 1363篇 |
综合类 | 367篇 |
现状与发展 | 2篇 |
一般理论 | 1篇 |
预防医学 | 1813篇 |
眼科学 | 112篇 |
药学 | 256篇 |
1篇 | |
中国医学 | 101篇 |
肿瘤学 | 880篇 |
出版年
2024年 | 66篇 |
2023年 | 421篇 |
2022年 | 138篇 |
2021年 | 302篇 |
2020年 | 513篇 |
2019年 | 195篇 |
2018年 | 591篇 |
2017年 | 618篇 |
2016年 | 641篇 |
2015年 | 736篇 |
2014年 | 745篇 |
2013年 | 1089篇 |
2012年 | 453篇 |
2011年 | 400篇 |
2010年 | 556篇 |
2009年 | 662篇 |
2008年 | 369篇 |
2007年 | 308篇 |
2006年 | 329篇 |
2005年 | 236篇 |
2004年 | 184篇 |
2003年 | 160篇 |
2002年 | 131篇 |
2001年 | 190篇 |
2000年 | 113篇 |
1999年 | 152篇 |
1998年 | 278篇 |
1997年 | 295篇 |
1996年 | 317篇 |
1995年 | 244篇 |
1994年 | 177篇 |
1993年 | 121篇 |
1992年 | 83篇 |
1991年 | 83篇 |
1990年 | 73篇 |
1989年 | 88篇 |
1988年 | 69篇 |
1987年 | 54篇 |
1986年 | 48篇 |
1985年 | 51篇 |
1984年 | 47篇 |
1983年 | 44篇 |
1982年 | 30篇 |
1981年 | 44篇 |
1980年 | 19篇 |
1979年 | 11篇 |
1978年 | 12篇 |
1977年 | 15篇 |
1976年 | 13篇 |
1975年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 421 毫秒
101.
The role of COX-2 in angiogenesis and rheumatoid arthritis 总被引:4,自引:0,他引:4
Woods JM Mogollon A Amin MA Martinez RJ Koch AE 《Experimental and molecular pathology》2003,74(3):282-290
Recent evidence suggests that cyclooxygenase (COX)-2 is a mediator of angiogenesis, and COX-2 activity is known to be upregulated in the rheumatoid arthritis (RA) synovium. We examined whether mediation of angiogenesis by COX-2 was occuring in cells of the RA synovium and in microvascular endothelial cells (ECs) that are similar to those found in the RA synovium. We demonstrate that rofecoxib, a selective COX-2 inhibitor, acts directly on human dermal microvascular ECs (HMVECs) to inhibit their chemotactic and tube forming ability. Likewise, pretreatment of HMVECs with rofecoxib significantly inhibited their ability to form tubes induced by conditioned media (CM) of activated RA synovial fibroblasts. When RA synovial fibroblasts were pretreated with rofecoxib for 16 h and then stimulated with interleukin (IL)-1beta, their CM induced significantly less HMVEC tube formation when compared with CM from vehicle-treated RA synovial fibroblasts. ELISAs performed on activated RA fibroblast CM for known proangiogenic factors demonstrated a significant reduction in bFGF, in addition to the expected decrease in PGE(2). Our studies suggest that COX-2-induced angiogenic activity is an active mechanism within diseased synovium and may provide an additional rationale for the use of COX-2 inhibitors in RA. 相似文献
102.
103.
James B. Harris MD Richard C. Ahrens MD Gary Milavetz PharmD Linda Annis Rebecca Ries BA Connie Hendricker RRT 《The Journal of allergy and clinical immunology》1990,85(6):1043-1049
Inhaled beta-agonists can produce bronchodilatation and reduce airway hyperreactivity in patients with asthma. Using these two measures, we compared inhaled bitolterol (three puffs, 1110 micrograms), albuterol (two puffs, 180 micrograms), and placebo administered by metered-dose inhaler in a blinded, crossover study of 40 subjects with chronic asthma. On each study day, subjects underwent histamine challenges at 1 1/2 hours before, and 1/2, 2, 4, 6, and 8 hours after inhaling one of the three test-drug treatments. Both drugs produced significant bronchodilatation at 30 minutes through 4 hours and significant effects on airway reactivity at 30 minutes through 2 hours (p less than 0.05). Bitolterol also produced small but significant bronchodilator effects at 6 hours and effects on airway reactivity at 4 hours (p less than 0.05). Effects of bitolterol on airway reactivity diminished significantly more slowly than effects of albuterol in subjects with baseline provocative concentration causing a 20% fall in FEV1 greater than or equal to 1.0 mg/ml of histamine (half-life of biologic effect 1.37 versus 0.92 hours; p less than 0.05) but not in subjects with baseline provocative concentration causing a 20% fall in FEV1 less than or equal to 1.0 mg/ml (half-life of biologic effect of 1.01 versus 1.00 hours; p greater than 0.05). 相似文献
104.
The reaction of the potassium salt of acrylic acid with the potassium salt of a dicarboxylic acid and 1,4-dibromobutane was applied to the synthesis of three series of acrylate-terminated copolyesters: poly(tetramethylene maleate-co-tetramethylene phthalate) (BMPA), poly(tetramethylene fumarate-co-tetramethylenephthalate) (BFPA) and poly(tetramethylene phthalate-co-tetramethylene succinate) (BPSA). The monofunctional monomer, the potassium salt of acrylic acid, was used for the introduction of double bonds at the end of the chains and for the regulation of the molecular weight of the polyesters. The telechelic copolyesters were characterized by 1H and 13C NMR spectroscopy, in almost all cases providing an acrylate functionality of two. 相似文献
105.
目的:观察在蛋白激酶C(PKC)激动剂TPPB促进可溶性淀粉样前体蛋白(sAPPα)释放过程中参与的信号转导通路。方法:以1 μmol/L的TPPB作用于PC12细胞3 h,同时加入信号转导通路的抑制剂,Western印迹法检测上清液内sAPPα的含量和细胞外信号调节激酶(p42/44MAPK)及磷酸化的p42/44MAPK的表达。结果:1 μmol/L的TPPB作用于PC12细胞3 h可以显著增加上清液内sAPPα的含量,细胞外信号调节激酶抑制剂U0126、c-Jun氨基末端激酶抑制剂SP600125和蛋白酪氨酸激酶抑制剂genistein可以部分消除此作用;而p38MAPK抑制剂SB203580对sAPPα的含量无显著影响。1 μmol/L的TPPB可以使磷酸化的p42/44MAPK表达增加,而对总的p42/44MAPK无显著影响。结论:细胞外信号调节激酶、c-Jun氨基末端激酶和蛋白酪氨酸激酶可能参与TPPB促进sAPPα生成的过程。 相似文献
106.
目的:制备不同栓塞范围的急性肺栓塞动物模型,研究血流动力学变化与肺栓塞范围的相关性。方法:经导管注入犬自体血栓选择性栓塞肺动脉,通过控制注入血栓数量、速度,分别建立不同栓塞范围的急性肺栓塞动物模型;比较栓前、栓后15 min、30 min、1 h及2 h血流动力学指标变化,同时观察心脏超声影像学变化。结果:自体血栓均按要求阻塞相应肺动脉,肺栓塞形成后心输出量下降,肺动脉压力及肺毛细血管楔压显著增高,并在0.5 -1 h达到峰值,各血流动力学指标随肺栓塞范围增大而变化更显著。结论:此急性肺栓塞动物模型制作方法确切可行。 相似文献
107.
108.
Shylaja Srinivasan Ling Chen Jennifer Todd Jasmin Divers Samuel Gidding Steven Chernausek Rose A. Gubitosi-Klug Megan M. Kelsey Rachana Shah Mary Helen Black Lynne E. Wagenknecht Alisa Manning Jason Flannick Giuseppina Imperatore Josep M. Mercader Dana Dabelea Jose C. Florez 《Diabetes》2021,70(4):996
The prevalence of type 2 diabetes in youth has increased substantially, yet the genetic underpinnings remain largely unexplored. To identify genetic variants predisposing to youth-onset type 2 diabetes, we formed ProDiGY, a multiethnic collaboration of three studies (TODAY, SEARCH, and T2D-GENES) with 3,006 youth case subjects with type 2 diabetes (mean age 15.1 ± 2.9 years) and 6,061 diabetes-free adult control subjects (mean age 54.2 ± 12.4 years). After stratifying by principal component–clustered ethnicity, we performed association analyses on ∼10 million imputed variants using a generalized linear mixed model incorporating a genetic relationship matrix to account for population structure and adjusting for sex. We identified seven genome-wide significant loci, including the novel locus rs10992863 in PHF2 (P = 3.2 × 10−8; odds ratio [OR] = 1.23). Known loci identified in our analysis include rs7903146 in TCF7L2 (P = 8.0 × 10−20; OR 1.58), rs72982988 near MC4R (P = 4.4 × 10−14; OR 1.53), rs200893788 in CDC123 (P = 1.1 × 10−12; OR 1.32), rs2237892 in KCNQ1 (P = 4.8 × 10−11; OR 1.59), rs937589119 in IGF2BP2 (P = 3.1 × 10−9; OR 1.34), and rs113748381 in SLC16A11 (P = 4.1 × 10−8; OR 1.04). Secondary analysis with 856 diabetes-free youth control subjects uncovered an additional locus in CPEB2 (P = 3.2 × 10−8; OR 2.1) and consistent direction of effect for diabetes risk. In conclusion, we identified both known and novel loci in the first genome-wide association study of youth-onset type 2 diabetes. 相似文献
109.